Depression does not affect the treatment outcome of CBT for panic and agoraphobia: Results from a multicenter randomized trial

Psychotherapy and Psychosomatics

Volumn 81, Issue 3, 2012, Pages 161-172

  Emmrich, Angela ^a   Beesdo Baum, Katja ^a   Gloster, Andrew T ^a   Knappe, Susanne ^a   Hfler, Michael ^a   Arolt, Volker ^b   Deckert, Jrgen ^c   Gerlach, Alexander L ^b,d   Hamm, Alfons ^e   Kircher, Tilo ^f   Lang, Thomas ^a,g   Richter, Jan ^e   Strhle, Andreas ^h   Zwanzger, Peter ^b   Wittchen, Hans Ulrich ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF GREIFSWALD   (Germany)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

^g UNIVERSITY OF BREMEN   (Germany)

^h Charit Universittsmedizin Berlin ^*  (Germany)

Author keywords

Agoraphobia; Cognitive behavioral therapy; Comorbidity; Depression; Exposure; Panic disorder; Randomized controlled trial

Indexed keywords

ADULT; AGORAPHOBIA; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DYSTHYMIA; FEMALE; FOLLOW UP; HAMILTON ANXIETY SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY (TOPIC); PANIC; POST HOC ANALYSIS; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; AGORAPHOBIA; COGNITIVE THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; LINEAR MODELS; MALE; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84857778688     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000335246     Document Type: Article

References (67)

1. Barlow DH, Gorman JM, Shear MK, Woods SW: Cognitive-behavioral therapy, imipramine, or their combination for panic disorder - a randomized controlled trial. JAMA 2000; 283: 2529-2536. (Pubitemid 30324195)
2. Clum GA, Clum GA, Surls R: A Metaanalysis of treatments for panic disorder. J Consult Clin Psychol 1993; 61: 317-326.
3. Gloster AT, Wittchen H-U, Einsle F, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW, Gerlach AL, Stroehle A, Kircher T, Deckert J, Zwanzger P, Hoefler M, Arolt V: Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. J Consult Clin Psychol 2011; 79: 406-420
4. McHugh RK, Smits JAJ, Otto MW: Empirically supported treatments for panic disorder. Psychiatr Clin North Am 2009; 32: 593-610.
5. Arch JJ, Craske MG: First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives. Psychiatr Clin North Am 2009; 32: 525-548.
6. Wittchen HU, Beesdo K, Bittner A, Goodwin RD: Depressive episodes - evidence for a causal role of primary anxiety disorders? Eur Psychiatry 2003; 18: 384-393. (Pubitemid 38009821)
7. Beesdo K, Pine DS, Lieb R, Wittchen HU: Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry 2010; 67: 47-57.
8. Bittner A, Goodwin RD, Wittchen HU, Beesdo K, Hofler M, Lieb R: What characteristics of primary anxiety disorders predict subsequent major depressive disorder? J Clin Psychiatry 2004; 65: 618-626.
9. Beesdo K, Bittner A, Pine DS, Stein MB, Hofler M, Lieb R, Wittchen HU: Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Arch Gen Psychiatry 2007; 64: 903-912. (Pubitemid 47230614)
10. Pine DS, Cohen P, Gurley D, Brook J, Ma YJ: The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998; 55: 56-64. (Pubitemid 28069040)
11. Wittchen HU: Natural course and spontaneous remission of untreated anxiety disorders: results of the Munich Follow-up Study (MFS); in Hand I, Wittchen HU (eds): Panic and Phobias II. Berlin, Springer, 1988, pp 3-17.
12. Goodwin RD: Anxiety disorders and the onset of depression among adults in the community. Psychol Med 2002; 32: 1121-1124.
13. Wittchen HU, Essau CA: Comorbidity of anxiety disorders and depression: does ist affect course and outcome? Psychiatr Psychobiol 1989; 4: 315-324.
14. Wittchen HU, Essau CA, Krieg JC: Anxiety disorders - similarities and differences of comorbidity in treated and untreated groups. Br J Psychiatry 1991; 159: 23-33.
15. Roy-Byrne PP, Stang P, Wittchen HU, Ustun B, Walters EE, Kessler RC: Lifetime panicdepression comorbidity in the National Comorbidity Survey - association with symptoms, impairment, course and help-seeking. Br J Psychiatry 2000; 176: 229-235. (Pubitemid 30179841)
16. Goodwin RD, Faravelli C, Rosi S, Cosci F, Truglia E, de Graaf R, Wittchen HU: The epidemiology of panic disorder and agoraphobia in Europe. Eur Neuropsychopharmacol 2005; 15: 435-443. (Pubitemid 40943547)
17. Goodwin RD, Olfson M: Treatment of panic attack and risk of major depressive disorder in the community. Am J Psychiatry 2001; 158: 1146-1148. (Pubitemid 32623121)
18. Johnson MR, Lydiard RB: Comorbidity of major depression and panic disorder. J Clin Psychol 1998; 54: 201-210. (Pubitemid 28063581)
19. Kessler RC, Stang PE, Wittchen HU, Ustun TB, Roy-Burne PP, Walters EE: Lifetime panic- depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry 1998; 55: 801-808. (Pubitemid 28413042)
20. Baldwin DS: Depression and panic: comorbidity. Eur Psychiatry 1998; 13: 65S-70S. (Pubitemid 28215846)
21. McLean PD, Woody S, Taylor S, Koch WJ: Comorbid panic disorder and major depression: implications for cognitive-behavioral therapy. J Consult Clin Psychol 1998; 66: 240-247. (Pubitemid 28208306)
22. Rief W, Trenkamp S, Auer C, Fichter MM: Cognitive behavior therapy in panic disorder and comorbid major depression - a naturalistic study. Psychother Psychosom 2000; 69: 70-78. (Pubitemid 30084871)
23. Allen LB, White KS, Barlow DH, Shear MK, Gorman JM, Woods SW: Cognitive-behavior therapy (CBT) for panic disorder: relationship of anxiety and depression comorbidity with treatment outcome. J Psychopathol Behav Assess 2010; 32: 185-192.
24. Laberge B, Gauthier JG, Cote G, Plamondon J, Cormier HJ: Cognitive-behavioral therapy of panic disorder with secondary major depression - a preliminary investigation. J Consult Clin Psychol 1993; 61: 1028-1037. (Pubitemid 24006593)
25. Maddock RJ, Blacker KH: Response to treatment in panic disorder with associated depression. Psychopathology 1991; 24: 1-6.
26. Albus M, Scheibe G, Scherer J: Panic disorder with or without concomitant depression 5 years after treatment: a prospective followup. J Affect Disord 1995; 34: 109-115.
27. Davis L, Barlow DH, Smith L: Comorbidity and the treatment of principal anxiety disorders in a naturalistic sample. Behav Ther 2010; 41: 296-305.
28. Rief W, Auer C, Wambach K, Fichter MM: Treatment of patients with panic disorder and comorbid depression. Z Klin Psychol Psychother 2003; 32: 210-218. (Pubitemid 36890004)
29. Dow MGT, Kenardy JA, Johnston DW, Newman MG, Taylor CB, Thomson A: Prognostic indices with brief and standard CBT for panic disorder. I. Predictors of outcome. Psychol Med 2007; 37: 1493-1502. (Pubitemid 47581419)
30. Tsao JCI, Mystkowski JL, Zucker BG, Craske MG: Effects of cognitive-behavioral therapy for panic disorder on comorbid conditions: replication and extension. Behav Ther 2002; 33: 493-509. (Pubitemid 36528763)
31. Basoglu M, Marks IM, Swinson RP, Noshirvani H, Osullivan G, Kuch K: Pretreatment predictors of treatment outcome in panic disorder and agoraphobia treated with Alprazolam and exposure. J Affect Disord 1994; 30: 123-132.
32. Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K, Klerman GL: Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord 1993; 28: 27-38. (Pubitemid 23146922)
33. Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB: Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162: 1179-1187. (Pubitemid 40770702)
34. Fava GA, Rafanelli C, Grandi S, Conti S, Ruini C, Mangelli L, Belluardo P: Long-term outcome of panic disorder with agoraphobia treated by exposure. Psychol Med 2001; 31: 891-898. (Pubitemid 32621897)
35. Noyes R, Clancy J, Woodman C, Holt CS, Suelzer M, Christiansen J, Anderson DJ: Environmental- factors related to the outcome of panic disorder - a 7-year follow-up study. J Nerv Ment Dis 1993; 181: 529-538. (Pubitemid 24259636)
36. Scheibe G, Albus M: Predictors of outcome in panic disorder: a 5-year prospective follow- up study. J Affect Disord 1996; 41: 111-116. (Pubitemid 26396469)
37. Steketee G, Chambless DL, Tran GQ: Effects of axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. Compr Psychiatry 2001; 42: 76-86. (Pubitemid 32095068)
38. van Balkom A, van Boeijen CA, Boeke AJP, van Oppen P, Kempe PT, van Dyck R: Comorbid depression, but not comorbid anxiety disorders, predicts poor outcome in anxiety disorders. Depress Anxiety 2008; 25: 408-415. (Pubitemid 351758599)
39. van Valkenburg C, Akiskal HS, Puzantian V, Rosenthal T: Anxious depressions clinical family history and naturalistic outcome comparisons with panic and major depressive disorder. J Affect Disord 1984; 6: 67-82. (Pubitemid 14158974)
40. Brown TA, Antony MM, Barlow DH: Diagnostic comorbidity in panic disorder: effect on treatment outcome and course of comorbid diagnoses following treatment. J Consult Clin Psychol 1995; 63: 408-418.
41. Pollack MH, Otto MW, Tesar GE, Cohen LS, Meltzerbrody S, Rosenbaum JF: Long-term outcome after acute treatment with alprazolam or clonazepram for panic disorder. J Clin Psychopharmacol 1993; 13: 257-263. (Pubitemid 23265164)
42. Keijsers GPJ, Hoogduin CAL, Schaap C: Prognostic factors in the behavioral treatment of panic disorder with and without agoraphobia. Behav Ther 1994; 25: 689-708.
43. Tsao JCI, Lewin MR, Craske MG: The effects of cognitive-behavior therapy for panic disorder on comorbid conditions. J Anxiety Disord 1998; 12: 357-371. (Pubitemid 28396184)
44. Tsao JCI, Mystkowski JL, Zucker BG, Craske MG: Impact of cognitive-behavioral therapy for panic disorder on comorbidity: a controlled investigation. Behav Res Ther 2005; 43: 959-970. (Pubitemid 40719615)
45. Woody S, McLean PD, Taylor S, Koch WJ: Treatment of major depression in the context of panic disorder. J Affect Disord 1999; 53: 163-174. (Pubitemid 29232356)
46. Gloster AT, Wittchen HU, Einsle F, Hofler M, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW, Gerlach AL, Strohle A, Kircher T, Deckert J, Zwanzger P, Arolt V: Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. Eur Arch Psych Clin Neurosci 2009; 259(suppl 2):S155-S166.
47. Gloster AT, Wittchen H-U, Einsle F, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW, Gerlach AL, Strohle A, Kircher T, Deckert J, Zwanzger P, Hofler M, Arolt V: Correction to Gloster et al. J Consult Clin Psychol 2011; 79: 652.
48. Wittchen HU, Pfister H: DIA-X-Interviews: Manual für Screening-Verfahren und Interview; Interviewheft Längsschnittuntersuchung (DIA-X-Lifetime); Ergänzungsheft (DIA-X-Lifetime); Interviewheft Querschnittuntersuchung (DIA-X-12-Monate); Ergänzungsheft (DIA-X-12-Monate); PCProgramm zur Durchführung des Interwiews (Längs- und Querschnittuntersuchung); Auswertungsprogramm. Frankfurt, Swets & Zeitlinger, 1997.
49. Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW, Pollack MH, Chandler L, Williams J, Ali A, Frank DM: Reliability and validity of a Structured Interview Guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety 2001; 13: 166-178. (Pubitemid 32550226)
50. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55.
51. Guy W: Clinical global impression; in Guy W (ed): EC-DEU assessment manual for psychopharmacology, revised. Rockville, National Institute of Mental Health, 1976, pp 217-222.
52. Bandelow B: Panic and Agoraphobia Scale (PAS). Ashland, Hogrefe & Huber Publishers, 1999.
53. Chambless DL, Caputo GC, Jasin SE, Gracely EJ, Williams C: The mobility inventory for agoraphobia. Behav Res Ther 1985; 23: 35-44. (Pubitemid 15146683)
54. Hautzinger M, Keller F, Kühner C: Beck Depressions-Inventar (BDI-II), revision. Frankfurt/Main, Harcourt Test Services, 2006.
55. Lang T, Helbig-Lang S, Westphal D, Gloster AT, Wittchen HU: Expositionsbasierte Therapie der Panikstörung mit Agoraphobie. Göttingen, Hogrefe, 2011.
56. Härdle W: Applied Nonparametric Regression (Biometric Society Monographs No. 19). Cambridge, Cambridge University Press, 1990.
57. Starcevic V, Uhlenhuth EH, Kellner R, Pathak D: Patterns of comorbidity in panic disorder and agoraphobia. Psychiatry Res 1992; 42: 171-183.
58. Fava GA: Statistical alchemy for drug treatment of generalized anxiety disorder: a commentary on the meta-analysis by Baldwin et al. [BMJ 2011; 342:d1199]. Psychother Psychosom 2011; 80: 261-263.
59. Pigott HE, Leventhal AM, Alter GS, Boren JJ: Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom 2010; 79: 267-279.
60. Craske MG, Farchione TJ, Allen LB, Barrios V, Stoyanova M, Rose R: Cognitive behavioral therapy for panic disorder and comorbidity: more of the same or less of more? Behav Res Ther 2007; 45: 1095-1109. (Pubitemid 46591964)
61. Hopko DR, Lejuez CW, Ruggiero KJ, Eifert GH: Contemporary behavioral activation treatments for depression: procedures, principles, and progress. Clin Psychol Rev 2003; 23: 699-717. (Pubitemid 37100984)
62. Jacobson NS, Martell CR, Dimidjian S: Behavioral activation treatment for depression: returning to contextual roots. Clin Psychol Sci Pract 2001; 8: 255-270. (Pubitemid 33681910)
63. Fava GA, Grandi S, Canestrari R, Grasso P, Pesarin F: Mechanisms of change of panic attacks with exposure treatment of agoraphobia. J Affect Disord 1991; 22: 65-71.
64. Chambless DL, Renneberg B, Gracely EJ, Goldstein AJ, Fydrich T: Axis I and II comorbidity in agoraphobia: prediction of psychotherapy outcome in a clinical setting. Psychother Res 2000; 10: 279-295.
65. Lang T, Helbig-Lang S: Exposure in vivo with and without presence of a therapist - Does it matter?; in Neudeck P, Wittchen HU (eds): Exposure Therapy: Rethinking the Model - Refining the Method. New York, Springer, in press.
66. Wittchen HU, Nocon A, Beesdo K, Pine DS, Hofler M, Lieb R, Gloster AT: Agoraphobia and panic. Psychother Psychosom 2008; 77: 147-157.
67. Wittchen HU, Gloster AT, Beesdo-Baum K, Fava GA, Craske MG: Agoraphobia: a review of the diagnostic classificatory position and criteria. Depress Anxiety 2010;27:113-133.